WO2022265320A1 - Drug packet inspection system - Google Patents

Drug packet inspection system Download PDF

Info

Publication number
WO2022265320A1
WO2022265320A1 PCT/KR2022/008287 KR2022008287W WO2022265320A1 WO 2022265320 A1 WO2022265320 A1 WO 2022265320A1 KR 2022008287 W KR2022008287 W KR 2022008287W WO 2022265320 A1 WO2022265320 A1 WO 2022265320A1
Authority
WO
WIPO (PCT)
Prior art keywords
image information
drug
package
medicine
unit
Prior art date
Application number
PCT/KR2022/008287
Other languages
French (fr)
Korean (ko)
Inventor
이용희
Original Assignee
(주)제이브이엠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)제이브이엠 filed Critical (주)제이브이엠
Publication of WO2022265320A1 publication Critical patent/WO2022265320A1/en

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
    • G01N21/9508—Capsules; Tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B07—SEPARATING SOLIDS FROM SOLIDS; SORTING
    • B07C—POSTAL SORTING; SORTING INDIVIDUAL ARTICLES, OR BULK MATERIAL FIT TO BE SORTED PIECE-MEAL, e.g. BY PICKING
    • B07C5/00—Sorting according to a characteristic or feature of the articles or material being sorted, e.g. by control effected by devices which detect or measure such characteristic or feature; Sorting by manually actuated devices, e.g. switches
    • B07C5/34—Sorting according to other particular properties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/8851—Scan or image signal processing specially adapted therefor, e.g. for scan signal adjustment, for detecting different kinds of defects, for compensating for structures, markings, edges
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/89—Investigating the presence of flaws or contamination in moving material, e.g. running paper or textiles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/89—Investigating the presence of flaws or contamination in moving material, e.g. running paper or textiles
    • G01N21/8901—Optical details; Scanning details
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/8851—Scan or image signal processing specially adapted therefor, e.g. for scan signal adjustment, for detecting different kinds of defects, for compensating for structures, markings, edges
    • G01N2021/8854—Grading and classifying of flaws
    • G01N2021/888—Marking defects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/8851—Scan or image signal processing specially adapted therefor, e.g. for scan signal adjustment, for detecting different kinds of defects, for compensating for structures, markings, edges
    • G01N2021/8887—Scan or image signal processing specially adapted therefor, e.g. for scan signal adjustment, for detecting different kinds of defects, for compensating for structures, markings, edges based on image processing techniques

Definitions

  • the present invention relates to a drug package inspection system, and more particularly, to a drug package inspection system for inspecting the accuracy of dispensing of a drug package constituting a bundle of drugs dispensed based on a prescription.
  • a drug packaging device is a device that automatically packages a drug stored in a drug storage unit in a drug wrapping paper for each dose according to a patient's prescription.
  • the drug packaging device automatically dispenses and collects the drug, and the collected drugs for a single dose are separated into drug wrapping paper. It is a device to be discharged after packaging.
  • a plurality of drug storage units each storing various drugs are arranged and installed on a mounting table, and drugs dispensed from a specific drug storage unit according to a prescription are discharged downward through a passage, and the dispensed drugs are collected in a hopper, The medicaments collected in the hopper are discharged to the lower side and sealed by the medicament wrapping paper so that they can be packaged.
  • the medicines to be taken by the patient are separated for each dose, packaged in a medicine wrapping paper, prepared in a bundle of medicine bags, and delivered to the patient in units of a medicine bag bundle.
  • a testing device has been developed that individually photographs each drug package constituting the drug package bundle, automatically compares the captured image with a reference image for the drug, and determines the accuracy of preparation based on the comparison result.
  • An object of the present invention is to check the accuracy of dispensing of a drug package dispensed based on a prescription, but to prevent drug accidents in advance by ensuring that there is no error in determining the accuracy even when the drugs constituting the drug package are in an abnormal situation. is to provide
  • the drug package inspection system includes a drug package inlet through which a bundle of drugs prepared based on a prescription is sequentially introduced; a photographing unit for individually photographing the medicine packs constituting the medicine pack bundle introduced through the medicine medicine inlet; Reference image information for the drug included in the medicine package - the reference image information includes top reference image information viewed from the top and side reference image information viewed from the side based on the state in which the drug is laid down - is stored image storage unit; an accuracy determining unit comparing the image information of the medicine package photographed by the photographing unit with the reference image information stored in the image storage unit to determine the accuracy of preparation of the medicine package; and a control unit configured to store the result determined by the accuracy determination unit in a result storage unit, wherein the accuracy determination unit determines whether the image information of the medicine package photographed by the photographing unit is the upper surface reference image information and the side reference image information.
  • the photographing unit If it is inconsistent with the image information, it is determined that the drug package is abnormal, and if the image information of the drug package photographed by the photographing unit matches the image information of the upper surface reference image, it is determined that the drug package is first normal, and the photographing unit If the image information of the medicine package photographed by the above matches the side reference image information, it may be characterized in that the medicine medicine is determined to be second normal.
  • the photographing unit of the drug package inspection system includes a vertical photographing unit for obtaining image information of the upper surface of the drug package by vertically photographing the drug package from an upper side or a lower side of the drug package that is moved in a lying state, and the accuracy
  • the determination unit may compare the top image information of the medicine pack with the top reference image information or the side reference image information to determine the preparation accuracy of the medicine pack.
  • the drug package inspection system further includes a display unit for continuously displaying image information on the upper surface of the drug packages constituting the drug package bundle, and the control unit controls the abnormal, first normal, and second normal images. It may be characterized in that normal medicines are displayed on the display unit to be distinguished from each other so that a manager can identify them.
  • the photographing unit of the drug package inspection system further includes an oblique photographing unit for obtaining oblique image information of the drug package by obliquely photographing the drug package from an upper side or a lower side of the drug package that is moved in a lying state. can do.
  • the control unit of the drug package inspection system displays top image information and perspective image information for a drug selected from among the drugs constituting the bundle of drugs based on a predetermined condition on the display unit, and At least one of top reference image information and side reference image information may be displayed on the display unit.
  • the predetermined conditions of the drug package inspection system include a first condition including a drug package determined to be abnormal by the accuracy determination unit, and a drug package determined to be abnormal by the accuracy determination unit and a second condition including a drug package determined to be normal by the accuracy determination unit. Any one of a second condition including medicines, a third condition including medicines judged to be second normal by the accuracy determination unit, or a fourth condition including all medicines constituting the medicines bundle, wherein the control unit determines the predetermined condition based on a condition selection input result input through the input unit among the first condition, the second condition, the third condition, and the fourth condition, and the drug that satisfies the predetermined condition It may be characterized in that image information for is sequentially displayed on the display unit.
  • the predetermined condition of the drug package inspection system is a condition including a drug package judged to be second normal by the accuracy determination unit, and the control unit, based on perspective image information on the selected drug package, inputs an input unit. It may be characterized in that the result stored in the result storage unit is maintained or modified based on the result input through the.
  • the drug package inspection system According to the drug package inspection system according to the present invention, even if the drugs constituting the drug package are placed in an abnormal state, there is no error in determining the accuracy of dispensing, so that drug accidents can be prevented in advance.
  • FIG. 1 is a block diagram illustrating a drug package inspection system according to the present invention.
  • FIG. 2 is a view for explaining a drug package inspection system according to the present invention.
  • 3 is an exemplary view of top surface reference image information for a circular medicine.
  • FIG. 4 is an exemplary diagram of side reference image information for a circular drug.
  • 5 to 7 are diagrams showing drug packages determined to be first normal by the drug package inspection system according to the present invention.
  • 8 to 13 are diagrams showing drug packages judged to be second normal by the drug package inspection system according to the present invention.
  • FIG. 14 is a diagram showing a drug package determined to be abnormal by the drug package inspection system according to the present invention.
  • 15 to 19 are diagrams for explaining a re-inspection process for a drug package determined to be second normal or abnormal by the drug package inspection system;
  • the drug package inspection system includes a drug package inlet through which a bundle of drugs prepared based on a prescription is sequentially introduced; a photographing unit for individually photographing the medicine packs constituting the medicine pack bundle introduced through the medicine medicine inlet; Reference image information for the drug included in the medicine package - the reference image information includes top reference image information viewed from the top and side reference image information viewed from the side based on the state in which the drug is laid down - is stored image storage unit; an accuracy determining unit comparing the image information of the medicine package photographed by the photographing unit with the reference image information stored in the image storage unit to determine the accuracy of preparation of the medicine package; and a control unit configured to store the result determined by the accuracy determination unit in a result storage unit, wherein the accuracy determination unit determines whether the image information of the medicine package photographed by the photographing unit is the upper surface reference image information and the side reference image information.
  • the photographing unit If it is inconsistent with the image information, it is determined that the drug package is abnormal, and if the image information of the drug package photographed by the photographing unit matches the image information of the upper surface reference image, it is determined that the drug package is first normal, and the photographing unit If the image information of the medicine package photographed by the above matches the side reference image information, it may be characterized in that the medicine medicine is determined to be second normal.
  • FIG. 1 is a block diagram for explaining a drug package inspection system according to the present invention
  • FIG. 2 is a diagram for explaining the drug package inspection system according to the present invention.
  • FIG. 3 is an exemplary diagram of top reference image information for a circular drug
  • FIG. 4 is an exemplary diagram of side reference image information for a circular drug.
  • the drug package inspection system 100 may be a known drug packaging device based on a patient's prescription or a system for checking the dispensing accuracy of manually dispensed drug packages.
  • the drug package inspection system 100 includes a drug package inlet 110 through which drug package bundles (MPRs) prepared based on a patient's prescription are sequentially introduced, and the drug package bundles (MPR) introduced through the drug package inlet 110 ), a photographing unit 120 for individually photographing the medicines constituting the medicines, an image storage unit 130 storing reference image information on drugs constituting the medicines, and an accuracy determination unit for determining the accuracy of preparation of the medicines 140 and a control unit 150 that controls the entire process.
  • MPRs drug package bundles
  • the drug package inlet 110 means an entrance through which the drugs constituting the drug package bundle (MPR) are sequentially introduced into the drug package inspection system 100 according to the present invention, and the drug package bundle (MPR) ) may be a concept relative to the outlet 190 for discharging the drug package to the outside of the drug package inspection system 100 according to the present invention.
  • the drug package inlet 110 may refer to an open space that allows the drug drug package (MPR) to be introduced in a laid-down state, and there is no particular limitation on size and shape.
  • MPR drug drug package
  • the photographing unit 120 is a kind of camera for individually photographing the medicine pills, vertically photographing the medicine pills from the top or bottom of the medicine pills being moved in a lying state, thereby obtaining image information of the upper surface of the medicine pills. It may include a unit 122 and an oblique photographing unit 124 for acquiring oblique image information of the medicine package by obliquely photographing the medicine package from an upper side or a lower side of the medicine package being moved in a lying state.
  • the top image information of the pill obtained by the vertical photographing unit 122 may include color image information and/or silhouette image information.
  • the oblique photographing unit 124 is relatively relative to the first oblique photographing unit 1242 located on the upstream side of the path along which the medicine bundle (MPR) moves, and the first oblique photographing unit 1242.
  • a second oblique photographing unit 1244 located on the downstream side may be included.
  • the oblique image information of the medicine package obtained by the oblique photographing unit 124 is image information used in a later re-examination process, and will be described in detail with reference to FIGS. 17 to 19 .
  • the movement of the medicine package MPR may be temporarily stopped, but is not necessarily limited thereto, and depending on the performance of the photographing unit 120 While the drug package MPR is moved, the drug packages may be individually photographed.
  • the image storage unit 130 may be a kind of storage medium that stores reference image information (PF, SF) for drugs constituting the medicine package.
  • the reference image information is based on the top surface viewed from the top based on the state in which the medicine is laid down, as shown in FIG.
  • Image information (PF) and, as shown in FIG. 4 may include side reference image information (SF) viewed from the side based on a state in which the drug is laid down.
  • the top reference image information (PF) and the side reference image information (SF) may include color image information and silhouette image information.
  • the reference image information may further include image information viewed from positions other than the upper side and the side side based on the lying state of the drug.
  • the accuracy determination unit 140 compares the image information of the drug package captured by the photographing unit 120 with the reference image information (PF, SF) stored in the image storage unit 130 to determine the preparation accuracy of the drug package. It may be a component that determines.
  • the accuracy determination unit 140 may compare the top image information of the medicine pack with the top reference image information (PF) or the side reference image information (SF) to determine the preparation accuracy of the medicine pack.
  • the accuracy determination unit 140 may determine that the drug package is normal or abnormal, and if it is determined to be normal, it may be determined to be first normal or second normal according to circumstances.
  • the control unit 150 is a component that stores the result determined by the accuracy determination unit 140 in the result storage unit 160, and the result storage unit 160 may be a kind of storage medium.
  • the drug package inspection system 100 may further include a display unit 170 for outputting image information on the upper surface of a drug package selected based on a predetermined condition among the drugs constituting the drug package MPR.
  • the display unit 170 may be a kind of touch panel, but is not necessarily limited thereto.
  • a manager such as a pharmacist may input a result value for the accuracy of dispensing through the input unit 180 through the image output by the display unit 170, and through this, the result value for the dispensing accuracy of the corresponding medicine is updated may be possible
  • the input unit 180 may be various input means such as an input means such as a keyboard or an input means on a touch panel.
  • FIGS. 8 and 13 are diagrams showing a drug package determined to be second normal by the drug package inspection system according to the present invention. It is a drawing showing
  • FIGS. 14 to 16 are diagrams showing drug packages determined to be abnormal by the drug package inspection system according to the present invention.
  • the medicine constituting one medicine package is defined, it will be assumed that the medicine is in the form of a low-height cylinder and the number is one pill.
  • the medicine M1 packaged in the medicine package MP is in a lying state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 7 .
  • the accuracy determination unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 7 into the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
  • the accuracy determination unit 140 may preferentially compare silhouette images with each other.
  • the accuracy determination unit 140 determines the accuracy of the drug package MP It is judged as the first normal.
  • the medicine M1 packaged in the medicine package MP is in a standing state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 10 .
  • the accuracy determining unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 10 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
  • the accuracy determination unit 140 may preferentially compare silhouette images with each other.
  • the accuracy determination unit 140 determines the accuracy of the drug package MP It is judged as the second normal.
  • 11 and 12 show the medicine package MP including half of the medicine M1 according to the patient's prescription in the medicine M2 packaged in the medicine package MP.
  • the medicine M2 packaged in the medicine package MP is in a standing state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 13 .
  • the accuracy determination unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 13 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
  • the accuracy determination unit 140 may preferentially compare silhouette images with each other.
  • the accuracy determining unit 140 determines the corresponding drug package MP as second normal.
  • FIG. 14 and 15 illustrate a medicine package MP including a single medicine M3, in which the medicine M3 packaged in the medicine package MP is different from the medicine M1 according to the patient's prescription.
  • the medicine M3 packaged in the medicine package MP is in a lying state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 16 .
  • the accuracy determination unit 140 converts the image information of the medicine package MP photographed by the vertical photographing unit 122, that is, the image information as shown in FIG. 16 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
  • the accuracy determination unit 140 may preferentially compare silhouette images with each other.
  • the accuracy determination unit ( 140) determines that the corresponding medicine package (MP) is abnormal.
  • the accuracy determination unit 140 converts the image information (see FIGS. 7, 10, 13, and 16) obtained by the vertical capture unit 122 into top reference image information PF or side reference image information ( SF), and as a result, an error may be made in determining accuracy in situations such as FIGS. 11 to 13.
  • the drug inspection system 100 since the drug inspection system 100 according to the present invention necessarily undergoes a re-inspection process as shown in FIGS. 17 to 19, the above errors are corrected in a later step.
  • 17 to 19 are diagrams for explaining a re-examination process for a drug package determined to be second normal or abnormal by the drug package inspection system.
  • the drug package inspection system 100 may include a display unit 170 for continuously displaying image information on the upper surface of the drug packages constituting the drug package (MPR). .
  • the medicines constituting the medicine package include a medicine medicine package (MP1) judged to be first normal by the accuracy determining unit 140 and a medicine medicine medicine cloth (MP2) determined to be second normal by the accuracy determination unit 140. and MP3s determined to be abnormal can be displayed on the display unit 170 so as to be distinguished from each other by the control unit 150, so that a manager such as a pharmacist can identify them.
  • MP1 medicine medicine package
  • MP2 medicine medicine medicine cloth
  • a first drug substance (MP1) determined to be normal is indicated by a black solid line
  • a drug substance (MP2) determined to be normal is indicated by a black dotted line
  • a drug substance (MP3) determined to be abnormal is indicated by a black dotted line.
  • the control unit 150 displays top image information and perspective image information on a drug package selected based on a predetermined condition from among the drug packages constituting the drug package MPR on the display unit 170, and displays the top surface of the selected drug package. At least one of the reference image information PF and the side reference image information SF may be displayed on the display unit 170 .
  • the predetermined condition includes a first condition including a drug package determined to be abnormal by the accuracy determination unit 140, a drug package determined to be abnormal by the accuracy determination unit and a second drug package determined to be normal. It may be any one of a second condition, a third condition including medicines judged to be second normal by the accuracy determination unit, or a fourth condition including all medicines constituting the medicine medicine bundle.
  • the control unit 150 may determine the predetermined condition based on a condition selection input result input through the input unit 180 among the first condition, the second condition, the third condition, and the fourth condition, Image information about medicines that satisfy the predetermined condition may be sequentially displayed on the display unit 170 .
  • 17 to 19 are diagrams illustrating the case where the predetermined condition is the second condition as an example.
  • the predetermined condition is the second condition
  • a manager such as a pharmacist applies a signal to display top image information and perspective image information on the display unit 170 through the input unit 180, as shown in FIG.
  • the top image information IM1 and perspective image information IM2 of the medicine package MP2 determined to be second normal are preferentially displayed on the display unit 170 .
  • the display unit 170 displays the top reference image information PF and the side reference image information SF for the drug based on the patient's prescription.
  • a manager such as a pharmacist can determine whether the result determined by the accuracy determination unit 140 is correct through the image information displayed on the display unit 170, in particular, the isometric image information IM2 for the corresponding medicine package. This can be viewed as a re-examination process.
  • a manager such as a pharmacist can know that the drug package is normal, and when a signal is applied through the input unit 180 to check the next drug package that needs to be retested, the control unit 150 returns to FIG. 18. As shown, top image information IM1 and oblique image information IM2 of the drug package MP3 determined to be abnormal can be displayed on the display unit 170 .
  • the result of the corresponding medicine package (MP3) stored in the result storage unit 160 may be maintained as it is.
  • a manager such as a pharmacist may input the re-inspection result value of the re-tested medicine package MP2 through the input unit 180 before checking the next medicine package that needs to be re-tested.
  • the medicine package corresponding to FIG. 17 may be changed from a black dotted line to a solid black line, or the result stored in the result storage unit 160 may be modified from the second normal to the first normal.
  • the result stored in the result storage unit 160 can be maintained or modified based on the result input through the input unit 180 by a manager such as a pharmacist.
  • the shape of the line is changed (if it is classified by color, the color is changed). application) or modification of the result stored in the result storage unit 160 may be automatically performed.
  • the manager such as a pharmacist, can know that the corresponding medicine package MP3 is abnormal through the isometric image information IM2 of the corresponding medicine package MP3, and the result determined by the accuracy determination unit 140 to be abnormal is accurate.
  • the controller 150 When a manager such as a pharmacist applies a signal through the input unit 180 to check the next medicine package MP2 that needs to be retested, the controller 150, as shown in FIG.
  • the top view image information IM1 and perspective image information IM2 for MP2 may be displayed on the display unit 170 .
  • a manager such as a pharmacist, can know that the corresponding medicine pack MP is an abnormal medicine pack through the perspective image information IM2 of the medicine pack MP, and can input this through the input unit 180.
  • the result value of the medicine package stored in the result storage unit 160 may be changed from second normal to abnormal.
  • the drug inspection system 100 makes the medicine package M2 determined to be second normal by the accuracy determination unit 140 a subject of re-inspection, thereby preventing errors in inspection in advance. , in the end, the possibility of a weakening accident can be prevented in advance.

Landscapes

  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

A drug packet inspection system, according to the present invention, may comprise: a drug packet inlet unit enabling the sequential entering of drug packet bundles which have been prepared on the basis of prescriptions; a capturing unit for individually capturing drug packets constituting the drug packet bundles which have entered through the drug packet inlet unit; an image storage unit for storing reference image information of a drug included in the drug packets, wherein the reference image information includes top reference image information in which the drug is viewed from above in a state where the drug is laid, and side reference image information in which the drug is viewed from a lateral side in a state where the drug is laid; an accuracy determination unit for determining the accuracy of preparation of the drug packets by comparing image information of the drug packets captured by the capturing unit with the reference image information stored in the image storage unit; and a control unit enabling the result determined by the accuracy determination unit to be stored in a result storage unit.

Description

약포 검사 시스템Drug Package Inspection System
본 발명은 약포 검사 시스템에 대한 것으로, 더욱 상세하게는 처방전에 기초하여 조제된 약포 다발을 구성하는 약포에 대해 조제의 정확성을 검사하기 위한 약포 검사 시스템에 관한 것이다.The present invention relates to a drug package inspection system, and more particularly, to a drug package inspection system for inspecting the accuracy of dispensing of a drug package constituting a bundle of drugs dispensed based on a prescription.
일반적으로 약제 포장 장치는 약제 보관 유닛에 보관된 약제를 환자의 처방전에 따라 약제 포장지에 1회 복용분 별로 자동으로 포장하는 장치이다.In general, a drug packaging device is a device that automatically packages a drug stored in a drug storage unit in a drug wrapping paper for each dose according to a patient's prescription.
구체적으로, 약제 포장 장치는 병원이나 약국 등에서 의사나 약사의 처방을 시스템을 통해 입력하면, 해당 약제의 불출 및 수집이 자동으로 이루어지고, 수집된 1회 복용분의 약제가 약제 포장지에 각각 분리되어 포장된 후 배출되도록 하는 장치이다.Specifically, when a prescription from a doctor or pharmacist is input through a system in a hospital or pharmacy, the drug packaging device automatically dispenses and collects the drug, and the collected drugs for a single dose are separated into drug wrapping paper. It is a device to be discharged after packaging.
약제 포장 장치는 다양한 약제가 각각 저장된 다수의 약제 보관 유닛이 설치대에 배열 설치되고, 처방에 따라 특정 약제 보관 유닛으로부터 불출된 약제가 통로를 통해 하측으로 불출되며, 불출된 약제는 호퍼에 모이게 되고, 호퍼에 모인 약제는 하측으로 배출되고 약제포장지에 의해 실링되어 포장될 수 있도록 한다.In the drug packaging device, a plurality of drug storage units each storing various drugs are arranged and installed on a mounting table, and drugs dispensed from a specific drug storage unit according to a prescription are discharged downward through a passage, and the dispensed drugs are collected in a hopper, The medicaments collected in the hopper are discharged to the lower side and sealed by the medicament wrapping paper so that they can be packaged.
위와 같은 과정을 통해 환자가 복용해야 하는 약제는 1회 복용분 별로 분리되어 약제 포장지에 포장되어 약포 다발로 조제되게 되며, 약포 다발 단위로 환자에게 전달되게 된다.Through the above process, the medicines to be taken by the patient are separated for each dose, packaged in a medicine wrapping paper, prepared in a bundle of medicine bags, and delivered to the patient in units of a medicine bag bundle.
여기서, 약제 포장 장치를 이용하여 약제를 1회 복용분 별로 조제하게 되면 편리성 및 신속성 등의 측면에서 장점이 있으나, 장치의 오작동이나 기타의 원인으로 인하여 약제가 잘못 포장되는 경우가 발생될 가능성이 항상 존재하여, 현재에는 조제의 정확성을 판단하는 검사 단계를 반드시 거치게 된다.Here, when the drug is prepared for each dose using the drug packaging device, there are advantages in terms of convenience and speed, but there is a possibility that the drug may be incorrectly packaged due to malfunction of the device or other causes It is always present, and now it must go through an inspection step to judge the accuracy of the formulation.
종래의 검사 방법으로는 약사 등의 관리자가 약제 포장 장치에 의해 조제된 약포 다발을 일일이 육안으로 관찰하여 검사를 하였으나, 이 경우 아침, 점심, 저녁별로 상이한 약제가 조제되는 경우에는 육안으로 확인하기 어렵다는 문제가 있다.In the conventional inspection method, a manager such as a pharmacist visually observed and inspected a bundle of medicine packages prepared by a drug packaging device. there is a problem.
이러한 이유로 약포 다발을 구성하는 약포를 개별적으로 촬영한 후 촬영된 영상을 해당 약제에 대한 기준 영상과 자동으로 비교하여 비교된 결과를 기초로 조제의 정확성을 판단하는 검사 장치가 개발되었다.For this reason, a testing device has been developed that individually photographs each drug package constituting the drug package bundle, automatically compares the captured image with a reference image for the drug, and determines the accuracy of preparation based on the comparison result.
그러나, 이러한 검사 장치는 약제 포장지에 포장된 약제가 파손된 경우, 약제가 기립된 상태인 경우 또는 약제가 서로 겹쳐져 있는 경우 등 비정상적인 상황에서는 조제의 정확성을 판단하는데 한계가 존재하였다.However, these inspection devices have limitations in determining the accuracy of dispensing in abnormal situations, such as when a drug packaged in a drug wrapper is damaged, when the drug is in a standing state, or when the drugs are overlapped with each other.
그러므로, 약제 포장 장치에 의해 조제된 약포를 검사하는데 있어서 비정상적인 상황에서도 조제의 정확성을 정확하게 판단할 수 있도록 하는 검사 시스템에 대한 연구 개발이 시급한 실정이다.Therefore, there is an urgent need to research and develop an inspection system capable of accurately determining the accuracy of dispensing even in an abnormal situation in inspecting the medicine package prepared by the medicine packaging device.
본 발명의 목적은 처방전에 기초하여 조제되는 약포에 대해 조제의 정확성을 검사하되, 약포를 구성하는 약제가 비정상적인 상황이라도 정확도 판단에 오류가 없도록 하여 약화사고를 미연에 방지할 수 있도록 하는 약포 검사 시스템을 제공하는 것이다.An object of the present invention is to check the accuracy of dispensing of a drug package dispensed based on a prescription, but to prevent drug accidents in advance by ensuring that there is no error in determining the accuracy even when the drugs constituting the drug package are in an abnormal situation. is to provide
본 발명에 따른 약포 검사 시스템은, 처방전에 기초하여 조제된 약포 다발이 순차적으로 유입되기 위한 약포 유입부; 상기 약포 유입부를 통해 유입된 상기 약포 다발을 구성하는 약포를 개별적으로 촬영하기 위한 촬영부; 상기 약포에 포함된 약제에 대한 기준 영상 정보 - 상기 기준 영상 정보는, 상기 약제가 눕혀진 상태를 기준으로 상측에서 바라본 상면 기준 영상 정보 및 측방에서 바라본 측면 기준 영상 정보를 포함함 - 가 저장되어 있는 영상 저장부; 상기 촬영부에 의해 촬영된 상기 약포의 영상 정보와 상기 영상 저장부에 저장된 상기 기준 영상 정보를 비교하여 상기 약포의 조제 정확도를 판단하는 정확도 판단부; 및 상기 정확도 판단부에 의해 판단된 결과가 결과 저장부에 저장되도록 하는 제어부;를 포함하며, 상기 정확도 판단부는, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보 및 상기 측면 기준 영상 정보와 불일치하면, 해당 약포에 대해 비정상으로 판단하고, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보와 일치하면, 해당 약포에 대해 제1 정상으로 판단하며, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 측면 기준 영상 정보와 일치하면, 해당 약포에 대해 제2 정상으로 판단하는 것을 특징으로 할 수 있다.The drug package inspection system according to the present invention includes a drug package inlet through which a bundle of drugs prepared based on a prescription is sequentially introduced; a photographing unit for individually photographing the medicine packs constituting the medicine pack bundle introduced through the medicine medicine inlet; Reference image information for the drug included in the medicine package - the reference image information includes top reference image information viewed from the top and side reference image information viewed from the side based on the state in which the drug is laid down - is stored image storage unit; an accuracy determining unit comparing the image information of the medicine package photographed by the photographing unit with the reference image information stored in the image storage unit to determine the accuracy of preparation of the medicine package; and a control unit configured to store the result determined by the accuracy determination unit in a result storage unit, wherein the accuracy determination unit determines whether the image information of the medicine package photographed by the photographing unit is the upper surface reference image information and the side reference image information. If it is inconsistent with the image information, it is determined that the drug package is abnormal, and if the image information of the drug package photographed by the photographing unit matches the image information of the upper surface reference image, it is determined that the drug package is first normal, and the photographing unit If the image information of the medicine package photographed by the above matches the side reference image information, it may be characterized in that the medicine medicine is determined to be second normal.
본 발명에 따른 약포 검사 시스템의 상기 촬영부는, 눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 수직하게 상기 약포를 촬영하여 상기 약포의 상면 영상 정보를 획득하기 위한 수직 촬영부를 포함하며, 상기 정확도 판단부는, 상기 약포의 상면 영상 정보를 상기 상면 기준 영상 정보 또는 상기 측면 기준 영상 정보와 비교하여 상기 약포의 조제 정확도를 판단하는 것을 특징으로 할 수 있다.The photographing unit of the drug package inspection system according to the present invention includes a vertical photographing unit for obtaining image information of the upper surface of the drug package by vertically photographing the drug package from an upper side or a lower side of the drug package that is moved in a lying state, and the accuracy The determination unit may compare the top image information of the medicine pack with the top reference image information or the side reference image information to determine the preparation accuracy of the medicine pack.
본 발명에 따른 약포 검사 시스템은, 상기 약포 다발을 구성하는 약포에 대한 상면 영상 정보를 연속적으로 표시하기 위한 디스플레이부;를 더 포함하며, 상기 제어부는, 상기 비정상, 상기 제1 정상 및 상기 제2 정상에 해당하는 약포에 대해 서로 구분되도록 상기 디스플레이부에 표시되도록 하여 관리자가 식별할 수 있도록 하는 것을 특징으로 할 수 있다.The drug package inspection system according to the present invention further includes a display unit for continuously displaying image information on the upper surface of the drug packages constituting the drug package bundle, and the control unit controls the abnormal, first normal, and second normal images. It may be characterized in that normal medicines are displayed on the display unit to be distinguished from each other so that a manager can identify them.
본 발명에 따른 약포 검사 시스템의 상기 촬영부는, 눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 경사지게 상기 약포를 촬영하여 상기 약포의 사시 영상 정보를 획득하기 위한 경사 촬영부를 더 포함하는 것을 특징으로 할 수 있다.The photographing unit of the drug package inspection system according to the present invention further includes an oblique photographing unit for obtaining oblique image information of the drug package by obliquely photographing the drug package from an upper side or a lower side of the drug package that is moved in a lying state. can do.
본 발명에 따른 약포 검사 시스템의 상기 제어부는, 상기 약포 다발을 구성하는 약포 중 미리 정해진 조건에 기초하여 선택된 약포에 대한 상면 영상 정보 및 사시 영상 정보가 디스플레이부에 표시되도록 하고, 상기 선택된 약포에 대한 상면 기준 영상 정보 및 측면 기준 영상 정보 중 적어도 하나가 상기 디스플레이부에 표시되도록 하는 것을 특징으로 할 수 있다.The control unit of the drug package inspection system according to the present invention displays top image information and perspective image information for a drug selected from among the drugs constituting the bundle of drugs based on a predetermined condition on the display unit, and At least one of top reference image information and side reference image information may be displayed on the display unit.
본 발명에 따른 약포 검사 시스템의 상기 미리 정해진 조건은, 상기 정확도 판단부에 의해 비정상으로 판단된 약포를 포함하는 제1 조건, 상기 정확도 판단부에 의해 비정상으로 판단된 약포 및 제2 정상으로 판단된 약포를 포함하는 제2 조건, 상기 정확도 판단부에 의해 제2 정상으로 판단된 약포를 포함하는 제3 조건, 또는 상기 약포 다발을 구성하는 약포 모두를 포함하는 제4 조건 중 어느 하나이며, 상기 제어부는, 상기 제1 조건, 상기 제2 조건, 상기 제3 조건 및 상기 제4 조건 중 입력부를 통해 입력된 조건 선택 입력 결과에 기초하여 상기 미리 정해진 조건을 결정하며, 상기 미리 정해진 조건을 만족하는 약포에 대한 영상 정보를 순차적으로 상기 디스플레이부에 표시되도록 하는 것을 특징으로 할 수 있다.The predetermined conditions of the drug package inspection system according to the present invention include a first condition including a drug package determined to be abnormal by the accuracy determination unit, and a drug package determined to be abnormal by the accuracy determination unit and a second condition including a drug package determined to be normal by the accuracy determination unit. Any one of a second condition including medicines, a third condition including medicines judged to be second normal by the accuracy determination unit, or a fourth condition including all medicines constituting the medicines bundle, wherein the control unit determines the predetermined condition based on a condition selection input result input through the input unit among the first condition, the second condition, the third condition, and the fourth condition, and the drug that satisfies the predetermined condition It may be characterized in that image information for is sequentially displayed on the display unit.
본 발명에 따른 약포 검사 시스템의 상기 미리 정해진 조건은, 상기 정확도 판단부에 의해 제2 정상으로 판단된 약포를 포함하는 조건이며, 상기 제어부는, 상기 선택된 약포에 대한 사시 영상 정보에 기초하여 입력부를 통해 입력된 결과에 기초하여 상기 결과 저장부에 저장된 결과가 유지되도록 하거나 수정되도록 하는 것을 특징으로 할 수 있다.The predetermined condition of the drug package inspection system according to the present invention is a condition including a drug package judged to be second normal by the accuracy determination unit, and the control unit, based on perspective image information on the selected drug package, inputs an input unit. It may be characterized in that the result stored in the result storage unit is maintained or modified based on the result input through the.
본 발명에 따른 약포 검사 시스템에 의하면, 약포를 구성하는 약제가 비정상적인 상태에 놓이더라도 조제의 정확도 판단에 오류가 없도록 하여 약화사고를 미연에 방지할 수 있다.According to the drug package inspection system according to the present invention, even if the drugs constituting the drug package are placed in an abnormal state, there is no error in determining the accuracy of dispensing, so that drug accidents can be prevented in advance.
또한, 조제의 정확도를 판단함에 있어 재검사 대상이 되는 약포의 선별이 정확하면서도 신속하고 편리하게 되도록 하여 편의성 및 효율성 등을 향상시킬 수 있다.In addition, in determining the accuracy of dispensing, it is possible to improve convenience and efficiency by making selection of drug packages to be retested accurately, quickly and conveniently.
도 1은 본 발명에 따른 약포 검사 시스템을 설명하기 위한 블록 구성도.1 is a block diagram illustrating a drug package inspection system according to the present invention.
도 2는 본 발명에 따른 약포 검사 시스템을 설명하기 위한 도면.2 is a view for explaining a drug package inspection system according to the present invention;
도 3은 원형의 약제에 대한 상면 기준 영상 정보의 예시 도면.3 is an exemplary view of top surface reference image information for a circular medicine.
도 4는 원형의 약제에 대한 측면 기준 영상 정보의 예시 도면.4 is an exemplary diagram of side reference image information for a circular drug.
도 5 내지 도 7은 본 발명에 따른 약포 검사 시스템에 의해 제1 정상으로 판단되는 약포를 도시한 도면.5 to 7 are diagrams showing drug packages determined to be first normal by the drug package inspection system according to the present invention.
도 8 내지 도 13은 본 발명에 따른 약포 검사 시스템에 의해 제2 정상으로 판단되는 약포를 도시한 도면.8 to 13 are diagrams showing drug packages judged to be second normal by the drug package inspection system according to the present invention.
도 14는 본 발명에 따른 약포 검사 시스템에 의해 비정상으로 판단되는 약포를 도시한 도면.14 is a diagram showing a drug package determined to be abnormal by the drug package inspection system according to the present invention.
도 15 내지 도 19는 약포 검사 시스템에 의해 제2 정상 또는 비정상으로 판단된 약포에 대해 재검사 과정을 설명하기 위한 도면.15 to 19 are diagrams for explaining a re-inspection process for a drug package determined to be second normal or abnormal by the drug package inspection system;
본 발명에 따른 약포 검사 시스템은, 처방전에 기초하여 조제된 약포 다발이 순차적으로 유입되기 위한 약포 유입부; 상기 약포 유입부를 통해 유입된 상기 약포 다발을 구성하는 약포를 개별적으로 촬영하기 위한 촬영부; 상기 약포에 포함된 약제에 대한 기준 영상 정보 - 상기 기준 영상 정보는, 상기 약제가 눕혀진 상태를 기준으로 상측에서 바라본 상면 기준 영상 정보 및 측방에서 바라본 측면 기준 영상 정보를 포함함 - 가 저장되어 있는 영상 저장부; 상기 촬영부에 의해 촬영된 상기 약포의 영상 정보와 상기 영상 저장부에 저장된 상기 기준 영상 정보를 비교하여 상기 약포의 조제 정확도를 판단하는 정확도 판단부; 및 상기 정확도 판단부에 의해 판단된 결과가 결과 저장부에 저장되도록 하는 제어부;를 포함하며, 상기 정확도 판단부는, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보 및 상기 측면 기준 영상 정보와 불일치하면, 해당 약포에 대해 비정상으로 판단하고, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보와 일치하면, 해당 약포에 대해 제1 정상으로 판단하며, 상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 측면 기준 영상 정보와 일치하면, 해당 약포에 대해 제2 정상으로 판단하는 것을 특징으로 할 수 있다.The drug package inspection system according to the present invention includes a drug package inlet through which a bundle of drugs prepared based on a prescription is sequentially introduced; a photographing unit for individually photographing the medicine packs constituting the medicine pack bundle introduced through the medicine medicine inlet; Reference image information for the drug included in the medicine package - the reference image information includes top reference image information viewed from the top and side reference image information viewed from the side based on the state in which the drug is laid down - is stored image storage unit; an accuracy determining unit comparing the image information of the medicine package photographed by the photographing unit with the reference image information stored in the image storage unit to determine the accuracy of preparation of the medicine package; and a control unit configured to store the result determined by the accuracy determination unit in a result storage unit, wherein the accuracy determination unit determines whether the image information of the medicine package photographed by the photographing unit is the upper surface reference image information and the side reference image information. If it is inconsistent with the image information, it is determined that the drug package is abnormal, and if the image information of the drug package photographed by the photographing unit matches the image information of the upper surface reference image, it is determined that the drug package is first normal, and the photographing unit If the image information of the medicine package photographed by the above matches the side reference image information, it may be characterized in that the medicine medicine is determined to be second normal.
이하에서는 도면을 참조하여 본 발명의 구체적인 실시예를 상세하게 설명한다. 다만, 본 발명의 사상은 제시되는 실시예에 제한되지 아니하고, 본 발명의 사상을 이해하는 당업자는 동일한 사상의 범위 내에서 다른 구성요소를 추가, 변경, 삭제 등을 통하여, 퇴보적인 다른 발명이나 본 발명 사상의 범위 내에 포함되는 다른 실시예를 용이하게 제안할 수 있을 것이나, 이 또한 본원 발명 사상 범위 내에 포함된다고 할 것이다. Hereinafter, specific embodiments of the present invention will be described in detail with reference to the drawings. However, the spirit of the present invention is not limited to the presented embodiments, and those skilled in the art who understand the spirit of the present invention may add, change, delete, etc. other elements within the scope of the same spirit, through other degenerative inventions or the present invention. Other embodiments included within the scope of the inventive idea can be easily proposed, but it will also be said to be included within the scope of the inventive concept.
또한, 각 실시예의 도면에 나타나는 동일한 사상의 범위 내의 기능이 동일한 구성요소는 동일한 참조부호를 사용하여 설명한다.In addition, components having the same function within the scope of the same idea appearing in the drawings of each embodiment are described using the same reference numerals.
도 1은 본 발명에 따른 약포 검사 시스템을 설명하기 위한 블록 구성도이며, 도 2는 본 발명에 따른 약포 검사 시스템을 설명하기 위한 도면이다.1 is a block diagram for explaining a drug package inspection system according to the present invention, and FIG. 2 is a diagram for explaining the drug package inspection system according to the present invention.
또한, 도 3은 원형의 약제에 대한 상면 기준 영상 정보의 예시 도면이며, 도 4는 원형의 약제에 대한 측면 기준 영상 정보의 예시 도면이다.In addition, FIG. 3 is an exemplary diagram of top reference image information for a circular drug, and FIG. 4 is an exemplary diagram of side reference image information for a circular drug.
도 1 및 도 2를 참조하면, 본 발명에 따른 약포 검사 시스템(100)은 환자의 처방전에 기초하여 공지의 약제 포장 장치 또는 수동으로 조제된 약포의 조제 정확도를 검사하기 위한 시스템일 수 있다.Referring to FIGS. 1 and 2 , the drug package inspection system 100 according to the present invention may be a known drug packaging device based on a patient's prescription or a system for checking the dispensing accuracy of manually dispensed drug packages.
상기 약포 검사 시스템(100)은 환자의 처방전에 기초하여 조제된 약포 다발(MPR)이 순차적으로 유입되기 위한 약포 유입부(110), 상기 약포 유입부(110)를 통해 유입된 상기 약포 다발(MPR)을 구성하는 약포를 개별적으로 촬영하기 위한 촬영부(120), 상기 약포를 구성하는 약제에 대한 기준 영상 정보가 저장되어 있는 영상 저장부(130), 상기 약포의 조제 정확도를 판단하는 정확도 판단부(140) 및 전체적인 절차를 제어하는 제어부(150) 등을 포함할 수 있다.The drug package inspection system 100 includes a drug package inlet 110 through which drug package bundles (MPRs) prepared based on a patient's prescription are sequentially introduced, and the drug package bundles (MPR) introduced through the drug package inlet 110 ), a photographing unit 120 for individually photographing the medicines constituting the medicines, an image storage unit 130 storing reference image information on drugs constituting the medicines, and an accuracy determination unit for determining the accuracy of preparation of the medicines 140 and a control unit 150 that controls the entire process.
상기 약포 유입부(110)는 약포 다발(MPR)을 구성하는 약포가 순차적으로 본 발명에따른 약포 검사 시스템(100)으로 유입되기 위한 입구를 의미하는 것으로, 조제의 정확도 검사가 완료된 약포 다발(MPR)을 구성하는 약포가 본 발명에 따른 약포 검사 시스템(100)의 외부로 배출되기 위한 출구(190)와 상대적인 개념일 수 있다.The drug package inlet 110 means an entrance through which the drugs constituting the drug package bundle (MPR) are sequentially introduced into the drug package inspection system 100 according to the present invention, and the drug package bundle (MPR) ) may be a concept relative to the outlet 190 for discharging the drug package to the outside of the drug package inspection system 100 according to the present invention.
상기 약포 유입부(110)는 약포 다발(MPR)이 눕혀진 상태로 유입될 수 있을 정도의 개방된 공간을 의미할 수 있으며, 크기 및 형상 등에 대해서는 특별한 제한이 존재하지 않는다.The drug package inlet 110 may refer to an open space that allows the drug drug package (MPR) to be introduced in a laid-down state, and there is no particular limitation on size and shape.
상기 촬영부(120)는 약포를 개별적으로 촬영하기 위한 일종의 카메라로, 눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 수직하게 상기 약포를 촬영하여 상기 약포의 상면 영상 정보를 획득하기 위한 수직 촬영부(122), 및 눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 경사지게 상기 약포를 촬영하여 상기 약포의 사시 영상 정보를 획득하기 위한 경사 촬영부(124)를 포함할 수 있다.The photographing unit 120 is a kind of camera for individually photographing the medicine pills, vertically photographing the medicine pills from the top or bottom of the medicine pills being moved in a lying state, thereby obtaining image information of the upper surface of the medicine pills. It may include a unit 122 and an oblique photographing unit 124 for acquiring oblique image information of the medicine package by obliquely photographing the medicine package from an upper side or a lower side of the medicine package being moved in a lying state.
상기 수직 촬영부(122)에 의해 획득되는 상기 약포의 상면 영상 정보는 컬러 영상 정보 및/또는 실루엣 영상 정보를 포함할 수 있다.The top image information of the pill obtained by the vertical photographing unit 122 may include color image information and/or silhouette image information.
상기 경사 촬영부(124)는 상기 약포 다발(MPR)이 이동되는 경로를 기준으로 상류측에 위치하는 제1 경사 촬영부(1242), 및 상기 제1 경사 촬영부(1242)를 기준으로 상대적으로 하류측에 위치하는 제2 경사 촬영부(1244)를 포함할 수 있다.The oblique photographing unit 124 is relatively relative to the first oblique photographing unit 1242 located on the upstream side of the path along which the medicine bundle (MPR) moves, and the first oblique photographing unit 1242. A second oblique photographing unit 1244 located on the downstream side may be included.
상기 경사 촬영부(124)에 의해 획득되는 상기 약포의 사시 영상 정보는 추후 재검사 과정에서 활용되는 영상 정보로, 도 17 내지 도 19를 참조로 하여 구체적으로 설명한다.The oblique image information of the medicine package obtained by the oblique photographing unit 124 is image information used in a later re-examination process, and will be described in detail with reference to FIGS. 17 to 19 .
상기 촬영부(120)에 의해 개별적으로 약포가 촬영되는 경우 상기 약포 다발(MPR)의 이동은 일시적으로 정지 상태일 수 있으나, 반드시 이에 한정되는 것은 아니며, 상기 촬영부(120)의 성능에 따라 상기 약포 다발(MPR)이 이동되면서 상기 약포가 개별적으로 촬영될 수도 있다.When the pills are individually photographed by the photographing unit 120, the movement of the medicine package MPR may be temporarily stopped, but is not necessarily limited thereto, and depending on the performance of the photographing unit 120 While the drug package MPR is moved, the drug packages may be individually photographed.
상기 영상 저장부(130)는 상기 약포를 구성하는 약제에 대한 기준 영상 정보(PF, SF)를 저장하는 일종의 저장 매체일 수 있다.The image storage unit 130 may be a kind of storage medium that stores reference image information (PF, SF) for drugs constituting the medicine package.
예를 들어, 상기 약포를 구성하는 약제가 낮은 높이의 원기둥 형태인 경우, 상기 기준 영상 정보(PF, SF)는 도 3에 도시된 바와 같이 상기 약제가 눕혀진 상태를 기준으로 상측에서 바라본 상면 기준 영상 정보(PF), 및 도 4에 도시된 바와 같이 상기 약제가 눕혀진 상태를 기준으로 측방에서 바라본 측면 기준 영상 정보(SF)를 포함할 수 있다.For example, when the medicine constituting the medicine package is in the form of a cylinder with a low height, the reference image information (PF, SF) is based on the top surface viewed from the top based on the state in which the medicine is laid down, as shown in FIG. Image information (PF) and, as shown in FIG. 4 , may include side reference image information (SF) viewed from the side based on a state in which the drug is laid down.
상기 상면 기준 영상 정보(PF) 및 상기 측면 기준 영상 정보(SF)는 컬러 영상 정보 및 실루엣 영상 정보를 포함할 수 있다.The top reference image information (PF) and the side reference image information (SF) may include color image information and silhouette image information.
상기 기준 영상 정보(PF, SF)는 상기 약제가 눕혀진 상태를 기준으로 상기 상측 및 상기 측방 이외의 위치에서 바라본 영상 정보를 더 포함할 수도 있다.The reference image information (PF, SF) may further include image information viewed from positions other than the upper side and the side side based on the lying state of the drug.
상기 정확도 판단부(140)는 상기 촬영부(120)에 의해 촬영된 상기 약포의 영상 정보와 상기 영상 저장부(130)에 저장된 상기 기준 영상 정보(PF, SF)를 비교하여 상기 약포의 조제 정확도를 판단하는 구성요소일 수 있다.The accuracy determination unit 140 compares the image information of the drug package captured by the photographing unit 120 with the reference image information (PF, SF) stored in the image storage unit 130 to determine the preparation accuracy of the drug package. It may be a component that determines.
상기 정확도 판단부(140)는 상기 약포의 상면 영상 정보를 상기 상면 기준 영상 정보(PF) 또는 상기 측면 기준 영상 정보(SF)와 비교하여 상기 약포의 조제 정확도를 판단할 수 있다.The accuracy determination unit 140 may compare the top image information of the medicine pack with the top reference image information (PF) or the side reference image information (SF) to determine the preparation accuracy of the medicine pack.
상기 정확도 판단부(140)는 해당 약포에 대해 정상 또는 비정상으로 판단할 수 있으며, 정상으로 판단하는 경우 상황에 따라 제1 정상 또는 제2 정상으로 판단할 수 있다.The accuracy determination unit 140 may determine that the drug package is normal or abnormal, and if it is determined to be normal, it may be determined to be first normal or second normal according to circumstances.
상기 정확도 판단부(140)에 의해 정상 또는 비정상으로 판단하는 구체적인 과정에 대해서는 도 5 내지 도 16을 참조로 구체적으로 설명한다.A specific process of determining normal or abnormal by the accuracy determining unit 140 will be described in detail with reference to FIGS. 5 to 16 .
상기 제어부(150)는 상기 정확도 판단부(140)에 의해 판단된 결과가 결과 저장부(160)에 저장되도록 하는 구성요소로, 상기 결과 저장부(160)는 일종의 저장 매체일 수 있다.The control unit 150 is a component that stores the result determined by the accuracy determination unit 140 in the result storage unit 160, and the result storage unit 160 may be a kind of storage medium.
한편, 본 발명에 따른 약포 검사 시스템(100)은 약포 다발(MPR)을 구성하는 약포 중 미리 정해진 조건에 기초하여 선택된 약포에 대한 상면 영상 정보 등을 출력하기 위한 디스플레이부(170)를 더 포함할 수 있으며, 상기 디스플레이부(170)는 일종의 터치 패널일 수 있으나 반드시 이에 한정되는 것은 아니다.On the other hand, the drug package inspection system 100 according to the present invention may further include a display unit 170 for outputting image information on the upper surface of a drug package selected based on a predetermined condition among the drugs constituting the drug package MPR. The display unit 170 may be a kind of touch panel, but is not necessarily limited thereto.
약사 등의 관리자는 상기 디스플레이부(170)에 의해 출력된 영상을 통해 조제의 정확도에 대한 결과값을 입력부(180)를 통해 입력할 수 있으며, 이를 통해 해당 약포의 조제 정확도에 대한 결과값은 업데이트가 가능할 수 있다.A manager such as a pharmacist may input a result value for the accuracy of dispensing through the input unit 180 through the image output by the display unit 170, and through this, the result value for the dispensing accuracy of the corresponding medicine is updated may be possible
여기서, 상기 입력부(180)는 키보드 등의 입력수단, 또는 터치 패널 상에서의 입력 수단 등 다양한 입력 수단일 수 있다.Here, the input unit 180 may be various input means such as an input means such as a keyboard or an input means on a touch panel.
도 5 내지 도 7은 본 발명에 따른 약포 검사 시스템에 의해 제1 정상으로 판단되는 약포를 도시한 도면이며, 도 8 및 도 13은 본 발명에 따른 약포 검사 시스템에 의해 제2 정상으로 판단되는 약포를 도시한 도면이다.5 to 7 are diagrams showing a drug package determined to be first normal by the drug package inspection system according to the present invention, and FIGS. 8 and 13 are diagrams showing a drug package determined to be second normal by the drug package inspection system according to the present invention. It is a drawing showing
또한, 도 14 내지 도 16은 본 발명에 따른 약포 검사 시스템에 의해 비정상으로 판단되는 약포를 도시한 도면이다.Also, FIGS. 14 to 16 are diagrams showing drug packages determined to be abnormal by the drug package inspection system according to the present invention.
구체적인 설명에 앞서, 하나의 약포를 구성하는 약제에 대해 정의하면, 상기 약제는 낮은 높이의 원기둥 형태이고, 개수는 한 알로 가정하여 설명한다.Prior to a detailed description, if the medicine constituting one medicine package is defined, it will be assumed that the medicine is in the form of a low-height cylinder and the number is one pill.
도 5 및 도 6은 약포(MP) 내에 포장된 약제(M1)는 한 알이고, 환자의 처방전에 맞게 정확한 약제(M1)가 포함된 약포(MP)를 도시하고 있다.5 and 6 show that the medicine M1 packaged in the medicine package MP is one pill, and the medicine package MP contains the medicine M1 exactly according to the patient's prescription.
상기 약포(MP) 내에 포장된 약제(M1)는 눕혀진 상태이며, 이로 인해 수직 촬영부(122)에 의해 촬영되어 획득되는 상면 영상 정보는 도 7과 같을 것이다.The medicine M1 packaged in the medicine package MP is in a lying state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 7 .
이 경우, 정확도 판단부(140)는 상기 수직 촬영부(122)에 의해 촬영된 약포(MP)의 영상 정보, 즉, 도 7과 같은 영상 정보를 상면 기준 영상 정보(PF, 도 3 참조) 또는 측면 기준 영상 정보(SF, 도 4 참조)와 비교하게 된다.In this case, the accuracy determination unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 7 into the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
여기서, 상기 정확도 판단부(140)는 실루엣 영상을 우선적으로 서로 비교할 수도 있다.Here, the accuracy determination unit 140 may preferentially compare silhouette images with each other.
도 5 내지 도 7의 경우, 상기 약포(MP)의 영상 정보(도 7 참조)가 상면 기준 영상 정보(PF)와 일치한 경우이므로, 상기 정확도 판단부(140)는 해당 약포(MP)에 대해 제1 정상으로 판단하게 된다.In the case of FIGS. 5 to 7 , since the image information (see FIG. 7 ) of the drug package MP matches the top reference image information PF, the accuracy determination unit 140 determines the accuracy of the drug package MP It is judged as the first normal.
도 8 및 도 9는 약포(MP) 내에 포장된 약제(M1)가 한 알이고, 환자의 처방전에 맞게 정확한 약제(M1)가 포함된 약포(MP)를 도시하고 있다.8 and 9 show the medicine package MP including one medicine M1 packaged in the medicine package MP and containing the medicine M1 exactly according to the patient's prescription.
상기 약포(MP) 내에 포장된 약제(M1)는 세워진 상태이며, 이로 인해 수직 촬영부(122)에 의해 촬영되어 획득되는 상면 영상 정보는 도 10과 같을 것이다.The medicine M1 packaged in the medicine package MP is in a standing state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 10 .
이 경우, 정확도 판단부(140)는 상기 수직 촬영부(122)에 의해 촬영된 약포(MP)의 영상 정보, 즉, 도 10과 같은 영상 정보를 상면 기준 영상 정보(PF, 도 3 참조) 또는 측면 기준 영상 정보(SF, 도 4 참조)와 비교하게 된다.In this case, the accuracy determining unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 10 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
여기서, 상기 정확도 판단부(140)는 실루엣 영상을 우선적으로 서로 비교할 수도 있다.Here, the accuracy determination unit 140 may preferentially compare silhouette images with each other.
도 8 내지 도 10의 경우, 상기 약포(MP)의 영상 정보(도 10 참조)가 측면 기준 영상 정보(SF)와 일치한 경우이므로, 상기 정확도 판단부(140)는 해당 약포(MP)에 대해 제2 정상으로 판단하게 된다.In the case of FIGS. 8 to 10, since the image information (see FIG. 10) of the drug package MP matches the side reference image information SF, the accuracy determination unit 140 determines the accuracy of the drug package MP It is judged as the second normal.
도 11 및 도 12는 약포(MP) 내에 포장된 약제(M2)가 환자의 처방전에 따른 약제(M1)의 반 알이 포함된 약포(MP)를 도시하고 있다.11 and 12 show the medicine package MP including half of the medicine M1 according to the patient's prescription in the medicine M2 packaged in the medicine package MP.
상기 약포(MP) 내에 포장된 약제(M2)는 세워진 상태이며, 이로 인해 수직 촬영부(122)에 의해 촬영되어 획득되는 상면 영상 정보는 도 13과 같을 것이다.The medicine M2 packaged in the medicine package MP is in a standing state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 13 .
이 경우, 정확도 판단부(140)는 상기 수직 촬영부(122)에 의해 촬영된 약포(MP)의 영상 정보, 즉, 도 13과 같은 영상 정보를 상면 기준 영상 정보(PF, 도 3 참조) 또는 측면 기준 영상 정보(SF, 도 4 참조)와 비교하게 된다.In this case, the accuracy determination unit 140 converts the image information of the medicine package MP captured by the vertical photographing unit 122, that is, the image information as shown in FIG. 13 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
여기서, 상기 정확도 판단부(140)는 실루엣 영상을 우선적으로 서로 비교할 수도 있다.Here, the accuracy determination unit 140 may preferentially compare silhouette images with each other.
도 11 내지 도 13의 경우, 상기 약포(MP)의 영상 정보가 측면 기준 영상 정보(SF)와 일치한 경우이므로, 상기 정확도 판단부(140)는 해당 약포(MP)에 대해 제2 정상으로 판단하게 된다.11 to 13, since the image information of the drug package MP matches the side reference image information SF, the accuracy determining unit 140 determines the corresponding drug package MP as second normal. will do
도 14 및 도 15는 약포(MP) 내에 포장된 약제(M3)가 환자의 처방전에 따른 약제(M1)와 상이한 한 알의 약제(M3)가 포함된 약포(MP)를 도시하고 있다.14 and 15 illustrate a medicine package MP including a single medicine M3, in which the medicine M3 packaged in the medicine package MP is different from the medicine M1 according to the patient's prescription.
상기 약포(MP) 내에 포장된 약제(M3)는 눕혀진 상태이며, 이로 인해 수직 촬영부(122)에 의해 촬영되어 획득되는 상면 영상 정보는 도 16과 같을 것이다.The medicine M3 packaged in the medicine package MP is in a lying state, and thus, the top image information obtained by being photographed by the vertical photographing unit 122 will be as shown in FIG. 16 .
이 경우, 정확도 판단부(140)는 상기 수직 촬영부(122)에 의해 촬영된 약포(MP)의 영상 정보, 즉, 도 16과 같은 영상 정보를 상면 기준 영상 정보(PF, 도 3 참조) 또는 측면 기준 영상 정보(SF, 도 4 참조)와 비교하게 된다.In this case, the accuracy determination unit 140 converts the image information of the medicine package MP photographed by the vertical photographing unit 122, that is, the image information as shown in FIG. 16 to the top surface reference image information (PF, see FIG. 3) or It is compared with the side reference image information (SF, see FIG. 4).
여기서, 상기 정확도 판단부(140)는 실루엣 영상을 우선적으로 서로 비교할 수도 있다.Here, the accuracy determination unit 140 may preferentially compare silhouette images with each other.
도 14 내지 도 16의 경우, 상기 약포(MP)의 영상 정보(도 16 참조)가 상기 상면 기준 영상 정보(PF) 및 상기 측면 기준 영상 정보(SF)와 불일치하는 경우이므로, 상기 정확도 판단부(140)는 해당 약포(MP)에 대해 비정상으로 판단하게 된다.14 to 16, since the image information (see FIG. 16) of the drug package MP is inconsistent with the top reference image information PF and the side reference image information SF, the accuracy determination unit ( 140) determines that the corresponding medicine package (MP) is abnormal.
상기와 같이 정확도 판단부(140)는 수직 촬영부(122)에 의해 획득되는 영상 정보(도 7, 도 10, 도 13 및 도 16 참조)를 상면 기준 영상 정보(PF) 또는 측면 기준 영상 정보(SF)와 비교 판단하며, 그 결과, 도 11 내지 도 13과 같은 상황에서는 정확도 판단에 오류를 범할 수 있다.As described above, the accuracy determination unit 140 converts the image information (see FIGS. 7, 10, 13, and 16) obtained by the vertical capture unit 122 into top reference image information PF or side reference image information ( SF), and as a result, an error may be made in determining accuracy in situations such as FIGS. 11 to 13.
그러나, 본 발명에 따른 약제 검사 시스템(100)은 도 17 내지 도 19에 도시된 바와 같이 재검사 과정을 반드시 거치게 되므로, 위와 같은 오류는 추후 단계에서 수정되게 된다.However, since the drug inspection system 100 according to the present invention necessarily undergoes a re-inspection process as shown in FIGS. 17 to 19, the above errors are corrected in a later step.
도 17 내지 도 19는 약포 검사 시스템에 의해 제2 정상 또는 비정상으로 판단된 약포에 대해 재검사 과정을 설명하기 위한 도면이다.17 to 19 are diagrams for explaining a re-examination process for a drug package determined to be second normal or abnormal by the drug package inspection system.
도 17 내지 도 19를 참조하면, 본 발명에 따른 약포 검사 시스템(100)은 약포 다발(MPR)을 구성하는 약포에 대한 상면 영상 정보를 연속적으로 표시하기 위한 디스플레이부(170)를 포함할 수 있다.Referring to FIGS. 17 to 19 , the drug package inspection system 100 according to the present invention may include a display unit 170 for continuously displaying image information on the upper surface of the drug packages constituting the drug package (MPR). .
상기 약포 다발(MPR)을 구성하는 약포는 도 17 내지 도 19에 도시된 바와 같이 정확도 판단부(140)에 의해 제1 정상으로 판단된 약포(MP1), 제2 정상으로 판단된 약포(MP2) 및 비정상로 판단된 약포(MP3)가 제어부(150)에 의해 서로 구분되도록 상기 디스플레이부(170)에 표시될 수 있으며, 이로 인해 약사 등의 관리자는 이를 식별할 수 있게 된다.As shown in FIGS. 17 to 19 , the medicines constituting the medicine package (MPR) include a medicine medicine package (MP1) judged to be first normal by the accuracy determining unit 140 and a medicine medicine medicine cloth (MP2) determined to be second normal by the accuracy determination unit 140. and MP3s determined to be abnormal can be displayed on the display unit 170 so as to be distinguished from each other by the control unit 150, so that a manager such as a pharmacist can identify them.
도 17 내지 도 19는 예를 들어 제1 정상으로 판단된 약포(MP1)를 검정색 실선으로 표시하고, 제2 정상으로 판단된 약포(MP2)를 검정색 점선으로 표시하며, 비정상로 판단된 약포(MP3)를 검정색 일점 쇄선으로 표시하여, 관리자가 식별할 수 있도록 한 상태를 도시하고 있다.17 to 19 , for example, a first drug substance (MP1) determined to be normal is indicated by a black solid line, a drug substance (MP2) determined to be normal is indicated by a black dotted line, and a drug substance (MP3) determined to be abnormal is indicated by a black dotted line. ) is displayed as a black one-dotted line, showing a state in which the manager can identify it.
제어부(150)는 상기 약포 다발(MPR)을 구성하는 약포 중 미리 정해진 조건에 기초하여 선택된 약포에 대한 상면 영상 정보 및 사시 영상 정보가 디스플레이부(170)에 표시되도록 하고, 상기 선택된 약포에 대한 상면 기준 영상 정보(PF) 및 측면 기준 영상 정보(SF) 중 적어도 하나가 상기 디스플레이부(170)에 표시되도록 할 수 있다.The control unit 150 displays top image information and perspective image information on a drug package selected based on a predetermined condition from among the drug packages constituting the drug package MPR on the display unit 170, and displays the top surface of the selected drug package. At least one of the reference image information PF and the side reference image information SF may be displayed on the display unit 170 .
여기서, 상기 미리 정해진 조건은 상기 정확도 판단부(140)에 의해 비정상으로 판단된 약포를 포함하는 제1 조건, 상기 정확도 판단부에 의해 비정상으로 판단된 약포 및 제2 정상으로 판단된 약포를 포함하는 제2 조건, 상기 정확도 판단부에 의해 제2 정상으로 판단된 약포를 포함하는 제3 조건, 또는 상기 약포 다발을 구성하는 약포 모두를 포함하는 제4 조건 중 어느 하나일 수 있다.Here, the predetermined condition includes a first condition including a drug package determined to be abnormal by the accuracy determination unit 140, a drug package determined to be abnormal by the accuracy determination unit and a second drug package determined to be normal. It may be any one of a second condition, a third condition including medicines judged to be second normal by the accuracy determination unit, or a fourth condition including all medicines constituting the medicine medicine bundle.
상기 제어부(150)는 상기 제1 조건, 상기 제2 조건, 상기 제3 조건 및 상기 제4 조건 중 입력부(180)를 통해 입력된 조건 선택 입력 결과에 기초하여 상기 미리 정해진 조건을 결정할 수 있으며, 상기 미리 정해진 조건을 만족하는 약포에 대한 영상 정보를 순차적으로 상기 디스플레이부(170)에 표시되도록 할 수 있다.The control unit 150 may determine the predetermined condition based on a condition selection input result input through the input unit 180 among the first condition, the second condition, the third condition, and the fourth condition, Image information about medicines that satisfy the predetermined condition may be sequentially displayed on the display unit 170 .
도 17 내지 도 19는 상기 미리 정해진 조건이 상기 제2 조건인 경우를 예로 들어 도시한 도면이다.17 to 19 are diagrams illustrating the case where the predetermined condition is the second condition as an example.
상기 미리 정해진 조건이 제2 조건인 경우, 약사 등의 관리자가 입력부(180)를 통해 상면 영상 정보 및 사시 영상 정보를 디스플레이부(170)에 표시되도록 하는 신호를 인가하면, 도 17에 도시된 바와 같이, 우선적으로 제2 정상으로 판단한 약포(MP2)에 대한 상면 영상 정보(IM1) 및 사시 영상 정보(IM2)가 상기 디스플레이부(170)에 표시된다.When the predetermined condition is the second condition, when a manager such as a pharmacist applies a signal to display top image information and perspective image information on the display unit 170 through the input unit 180, as shown in FIG. Similarly, the top image information IM1 and perspective image information IM2 of the medicine package MP2 determined to be second normal are preferentially displayed on the display unit 170 .
이때, 상기 디스플레이부(170)에는 환자의 처방전에 기초한 약제에 대한 상면 기준 영상 정보(PF) 및 측면 기준 영상 정보(SF)가 표시된다.At this time, the display unit 170 displays the top reference image information PF and the side reference image information SF for the drug based on the patient's prescription.
약사 등의 관리자는 상기 디스플레이부(170)에 표시된 영상 정보, 특히, 해당 약포에 대한 사시 영상 정보(IM2)를 통해 정확도 판단부(140)가 판단한 결과가 정확한지를 판단할 수 있으며, 이러한 과정이 재검사 과정이라고 볼 수 있다.A manager such as a pharmacist can determine whether the result determined by the accuracy determination unit 140 is correct through the image information displayed on the display unit 170, in particular, the isometric image information IM2 for the corresponding medicine package. This can be viewed as a re-examination process.
도 17의 경우, 약사 등의 관리자는 해당 약포가 정상이라는 것을 알 수 있으며, 재검사가 필요한 다음 약포의 확인 작업을 위해 입력부(180)를 통해 신호를 인가하면, 상기 제어부(150)는 도 18에 도시된 바와 같이 비정상으로 판단된 약포(MP3)에 대한 상면 영상 정보(IM1) 및 사시 영상 정보(IM2)가 상기 디스플레이부(170)에 표시되도록 할 수 있다.In the case of FIG. 17, a manager such as a pharmacist can know that the drug package is normal, and when a signal is applied through the input unit 180 to check the next drug package that needs to be retested, the control unit 150 returns to FIG. 18. As shown, top image information IM1 and oblique image information IM2 of the drug package MP3 determined to be abnormal can be displayed on the display unit 170 .
이때, 결과 저장부(160)에 저장된 해당 약포(MP3)에 대한 결과는 그대로 유지될 수 있다.At this time, the result of the corresponding medicine package (MP3) stored in the result storage unit 160 may be maintained as it is.
한편, 약사 등의 관리자는 재검사가 필요한 다음 약포의 확인 작업 이전에 재검사가 완료된 약포(MP2)에 대해 재검사한 결과값을 상기 입력부(180)를 통해 입력할 수도 있다.On the other hand, a manager such as a pharmacist may input the re-inspection result value of the re-tested medicine package MP2 through the input unit 180 before checking the next medicine package that needs to be re-tested.
이 경우, 도 17에 해당하는 약포는 검정색 점선에서 검정색 실선으로 변경되거나 결과 저장부(160)에 저장된 결과가 제2 정상에서 제1 정상으로 수정될 수 있다.In this case, the medicine package corresponding to FIG. 17 may be changed from a black dotted line to a solid black line, or the result stored in the result storage unit 160 may be modified from the second normal to the first normal.
다시 말하면, 상기 결과 저장부(160)에 저장된 결과는 약사 등의 관리자에 의해 상기 입력부(180)를 통해 입력된 결과에 기초하여 그대로 유지되거나 수정될 수 있는 것이다.In other words, the result stored in the result storage unit 160 can be maintained or modified based on the result input through the input unit 180 by a manager such as a pharmacist.
물론, 약사 등의 관리자가 상기 입력부(180)를 통한 입력 없이 바로 재검사가 필요한 다음 약포(MP3)의 확인 작업을 위한 신호를 인가한 경우, 선의 형태의 변경(색상으로 구분된 경우에는 색상 변경을 적용) 또는 결과 저장부(160)에 저장된 결과의 수정 등이 자동적으로 수행되도록 할 수도 있을 것이다.Of course, when a manager such as a pharmacist applies a signal for checking the next drug pack (MP3) that needs to be retested immediately without input through the input unit 180, the shape of the line is changed (if it is classified by color, the color is changed). application) or modification of the result stored in the result storage unit 160 may be automatically performed.
도 18의 경우, 약사 등의 관리자는 해당 약포(MP3)의 사시 영상 정보(IM2)를 통해 해당 약포(MP)가 비정상이라는 것을 알 수 있으며, 정확도 판단부(140)가 비정상으로 판단한 결과가 정확하다는 것을 알 수 있다.In the case of FIG. 18 , the manager, such as a pharmacist, can know that the corresponding medicine package MP3 is abnormal through the isometric image information IM2 of the corresponding medicine package MP3, and the result determined by the accuracy determination unit 140 to be abnormal is accurate. it can be seen that
약사 등의 관리자는 재검사가 필요한 다음 약포(MP2)의 확인 작업을 위해 입력부(180)를 통해 신호를 인가하면, 상기 제어부(150)는 도 19에 도시된 바와 같이 제2 정상으로 판단된 약포(MP2)에 대한 상면 영상 정보(IM1) 및 사시 영상 정보(IM2)가 상기 디스플레이부(170)에 표시되도록 할 수 있다.When a manager such as a pharmacist applies a signal through the input unit 180 to check the next medicine package MP2 that needs to be retested, the controller 150, as shown in FIG. The top view image information IM1 and perspective image information IM2 for MP2 may be displayed on the display unit 170 .
약사 등의 관리자는 해당 약포(MP)의 사시 영상 정보(IM2)를 통해 해당 약포(MP)가 비정상 약포라는 것을 알 수 있으며, 이를 입력부(180)를 통해 입력할 수 있다.A manager, such as a pharmacist, can know that the corresponding medicine pack MP is an abnormal medicine pack through the perspective image information IM2 of the medicine pack MP, and can input this through the input unit 180.
상기 입력부(180)를 통해 결과값이 입력되면, 결과 저장부(160)에 저장된 해당 약포의 결과값은 제2 정상에서 비정상으로 변경될 수 있다.When the result value is input through the input unit 180, the result value of the medicine package stored in the result storage unit 160 may be changed from second normal to abnormal.
또한, 검정색 점선에서 검정색 일점쇄선으로 변경될 수도 있을 것이다.Also, it may be changed from a black dotted line to a black dotted line.
상기와 같이 본 발명에 따른 약제 검사 시스템(100)은 정확도 판단부(140)에 의해 제2 정상으로 판단된 약포(M2)에 대해 재검사 대상이 되도록 함으로써, 검사의 오류를 미연에 방지할 수 있으며, 결국, 약화사고의 발생 가능성이 미연에 차단할 수 있다.As described above, the drug inspection system 100 according to the present invention makes the medicine package M2 determined to be second normal by the accuracy determination unit 140 a subject of re-inspection, thereby preventing errors in inspection in advance. , in the end, the possibility of a weakening accident can be prevented in advance.
또한, 재검사의 대상이 되는 약포를 미리 정해 놓음으로서 모든 약포를 재검사하는 등의 시간적인 낭비를 최소화할 수 있다.In addition, by pre-determining the drug packages to be re-tested, time waste such as re-examination of all drug packages can be minimized.
물론, 경우에 따라서는 재검사의 대상이 되는 약포가 모든 약포가 되도록 하는 설정도 가능할 것이다.Of course, depending on the case, it may be possible to set all drug packages to be retested.
상기에서는 본 발명에 따른 실시예를 기준으로 본 발명의 구성과 특징을 설명하였으나 본 발명은 이에 한정되지 않으며, 본 발명의 사상과 범위 내에서 다양하게 변경 또는 변형할 수 있음은 본 발명이 속하는 기술분야의 당업자에게 명백한 것이며, 따라서 이와 같은 변경 또는 변형은 첨부된 특허청구범위에 속함을 밝혀둔다.In the above, the configuration and characteristics of the present invention have been described based on the embodiments according to the present invention, but the present invention is not limited thereto, and various changes or modifications can be made within the spirit and scope of the present invention. It is apparent to those skilled in the art, and therefore such changes or modifications are intended to fall within the scope of the appended claims.

Claims (7)

  1. 처방전에 기초하여 제조된 약포 다발이 순차적으로 유입되기 위한 약포 유입부;a drug package inlet through which a bundle of drugs manufactured based on a prescription is sequentially introduced;
    상기 약포 유입부를 통해 유입된 상기 약포 다발을 구성하는 약포를 개별적으로 촬영하기 위한 촬영부;a photographing unit for individually photographing the medicine packs constituting the medicine pack bundle introduced through the medicine medicine inlet;
    상기 약포를 구성하는 약제에 대한 기준 영상 정보 - 상기 기준 영상 정보는, 상기 약제가 눕혀진 상태를 기준으로 상측에서 바라본 상면 기준 영상 정보 및 측방에서 바라본 측면 기준 영상 정보를 포함함 - 가 저장되어 있는 영상 저장부;Reference image information about the medicine constituting the medicine package, wherein the reference image information includes top reference image information viewed from the top and side reference image information viewed from the side based on the lying state of the medicine - stored therein image storage unit;
    상기 촬영부에 의해 촬영된 상기 약포의 영상 정보와 상기 영상 저장부에 저장된 상기 기준 영상 정보를 비교하여 상기 약포의 조제 정확도를 판단하는 정확도 판단부; 및an accuracy determining unit comparing the image information of the medicine package photographed by the photographing unit with the reference image information stored in the image storage unit to determine the accuracy of preparation of the medicine package; and
    상기 정확도 판단부에 의해 판단된 결과가 결과 저장부에 저장되도록 하는 제어부;를 포함하며, A control unit for storing the result determined by the accuracy determination unit in a result storage unit; includes,
    상기 정확도 판단부는,The accuracy determination unit,
    상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보 및 상기 측면 기준 영상 정보와 불일치하면, 해당 약포에 대해 비정상으로 판단하고,If the image information of the medicine package photographed by the photographing unit is inconsistent with the top reference image information and the side reference image information, it is determined that the medicine package is abnormal;
    상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 상면 기준 영상 정보와 일치하면, 해당 약포에 대해 제1 정상으로 판단하며,If the image information of the drug package photographed by the photographing unit matches the top surface reference image information, it is determined that the drug package is first normal;
    상기 촬영부에 의해 촬영된 약포의 영상 정보가 상기 측면 기준 영상 정보와 일치하면, 해당 약포에 대해 제2 정상으로 판단하는 것을 특징으로 하는 약포 검수 시스템.If the image information of the drug package photographed by the photographing unit matches the side reference image information, the drug product inspection system is characterized in that the drug product is judged to be second normal.
  2. 제1항에 있어서,According to claim 1,
    상기 촬영부는,the filming unit,
    눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 수직하게 상기 약포를 촬영하여 상기 약포의 상면 영상 정보를 획득하기 위한 수직 촬영부를 포함하며,A vertical photographing unit for vertically photographing the medicine package from an upper side or a lower side of the medicine package being moved in a lying state to obtain image information of the top surface of the medicine package;
    상기 정확도 판단부는,The accuracy determination unit,
    상기 약포의 상면 영상 정보를 상기 상면 기준 영상 정보 또는 상기 측면 기준 영상 정보와 비교하여 상기 약포의 조제 정확도를 판단하는 것을 특징으로 하는 약포 검수 시스템.The medicine package inspection system, characterized in that the preparation accuracy of the medicine package is determined by comparing the top image information of the medicine package with the top surface reference image information or the side reference image information.
  3. 제2항에 있어서,According to claim 2,
    상기 약포 다발을 구성하는 약포에 대한 상면 영상 정보를 연속적으로 표시하기 위한 디스플레이부;를 더 포함하며,It further includes a display unit for continuously displaying upper surface image information on the medicine pills constituting the medicine pill bundle,
    상기 제어부는,The control unit,
    상기 비정상, 상기 제1 정상 및 상기 제2 정상에 해당하는 약포에 대해 서로 구분되도록 상기 디스플레이부에 표시되도록 하여 관리자가 식별할 수 있도록 하는 것을 특징으로 하는 약포 검수 시스템.The drug product inspection system characterized in that the medicines corresponding to the abnormal, the first normal, and the second normal are displayed on the display unit to be distinguished from each other so that a manager can identify them.
  4. 제2항에 있어서,According to claim 2,
    상기 촬영부는,the filming unit,
    눕혀진 상태로 이동되는 상기 약포의 상측 또는 하측에서 경사지게 상기 약포를 촬영하여 상기 약포의 사시 영상 정보를 획득하기 위한 경사 촬영부를 더 포함하는 것을 특징으로 하는 약포 검수 시스템.The drug product inspection system further comprising an oblique photographing unit for obtaining oblique image information of the drug package by obliquely photographing the drug package from an upper side or a lower side of the drug package that is moved in a lying state.
  5. 제4항에 있어서,According to claim 4,
    상기 제어부는,The control unit,
    상기 약포 다발을 구성하는 약포 중 미리 정해진 조건에 기초하여 선택된 약포에 대한 상면 영상 정보 및 사시 영상 정보가 디스플레이부에 표시되도록 하고, 상기 선택된 약포에 대한 상면 기준 영상 정보 및 측면 기준 영상 정보 중 적어도 하나가 상기 디스플레이부에 표시되도록 하는 것을 특징으로 하는 약포 검수 시스템.Top image information and perspective image information for a drug package selected based on a predetermined condition among the drug packages constituting the drug package bundle are displayed on a display unit, and at least one of upper surface reference image information and side reference image information for the selected drug package. The drug package inspection system, characterized in that to display on the display unit.
  6. 제5항에 있어서,According to claim 5,
    상기 미리 정해진 조건은,The predetermined condition is,
    상기 정확도 판단부에 의해 비정상으로 판단된 약포를 포함하는 제1 조건, 상기 정확도 판단부에 의해 비정상으로 판단된 약포 및 제2 정상으로 판단된 약포를 포함하는 제2 조건, 상기 정확도 판단부에 의해 제2 정상으로 판단된 약포를 포함하는 제3 조건, 또는 상기 약포 다발을 구성하는 약포 모두를 포함하는 제4 조건 중 어느 하나이며,A first condition including a drug product determined to be abnormal by the accuracy determination unit, a second condition including a drug product determined to be abnormal by the accuracy determination unit and a drug product determined to be normal in a second condition, by the accuracy determination unit Any one of the third condition including the drug package judged to be second normal, or the fourth condition including all the drug packages constituting the bundle of the drug package,
    상기 제어부는,The control unit,
    상기 제1 조건, 상기 제2 조건, 상기 제3 조건 및 상기 제4 조건 중 입력부를 통해 입력된 조건 선택 입력 결과에 기초하여 상기 미리 정해진 조건을 결정하며, 상기 미리 정해진 조건을 만족하는 약포에 대한 영상 정보를 순차적으로 상기 디스플레이부에 표시되도록 하는 것을 특징으로 하는 약포 검수 시스템.The predetermined condition is determined based on a condition selection input result input through an input unit among the first condition, the second condition, the third condition, and the fourth condition, and The drug product inspection system characterized in that the image information is sequentially displayed on the display unit.
  7. 제5항에 있어서,According to claim 5,
    상기 미리 정해진 조건은,The predetermined condition is,
    상기 정확도 판단부에 의해 제2 정상으로 판단된 약포를 포함하는 조건이며,A condition including a drug package judged to be second normal by the accuracy determination unit,
    상기 제어부는,The control unit,
    상기 선택된 약포에 대한 사시 영상 정보에 기초하여 입력부를 통해 입력된 결과에 기초하여 상기 결과 저장부에 저장된 결과가 유지되도록 하거나 수정되도록 하는 것을 특징으로 하는 약포 검수 시스템.The drug product inspection system, characterized in that the result stored in the result storage unit is maintained or modified based on the result input through the input unit based on the perspective image information on the selected drug package.
PCT/KR2022/008287 2021-06-14 2022-06-13 Drug packet inspection system WO2022265320A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2021-0076802 2021-06-14
KR1020210076802A KR20220167613A (en) 2021-06-14 2021-06-14 Medicine package inspection system

Publications (1)

Publication Number Publication Date
WO2022265320A1 true WO2022265320A1 (en) 2022-12-22

Family

ID=84527186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/008287 WO2022265320A1 (en) 2021-06-14 2022-06-13 Drug packet inspection system

Country Status (2)

Country Link
KR (1) KR20220167613A (en)
WO (1) WO2022265320A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120124234A (en) * 2011-05-03 2012-11-13 (주)제이브이엠 Automatic reinspection system and the method of prescription drugs
US20150302255A1 (en) * 2012-01-23 2015-10-22 Perceptimed, Inc. Automated Pharmaceutical Pill Identification
KR20170001467A (en) * 2015-06-26 2017-01-04 (주)제이브이엠 Medicine packets inspection apparatus and method for inspecting medicine packets
KR101943217B1 (en) * 2017-08-31 2019-01-30 정혜원 Method and devices for pill identification
KR20200062533A (en) * 2018-11-27 2020-06-04 신종걸 Apparatus for Checking Packaging Equipment Automation Machine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120124234A (en) * 2011-05-03 2012-11-13 (주)제이브이엠 Automatic reinspection system and the method of prescription drugs
US20150302255A1 (en) * 2012-01-23 2015-10-22 Perceptimed, Inc. Automated Pharmaceutical Pill Identification
KR20170001467A (en) * 2015-06-26 2017-01-04 (주)제이브이엠 Medicine packets inspection apparatus and method for inspecting medicine packets
KR101943217B1 (en) * 2017-08-31 2019-01-30 정혜원 Method and devices for pill identification
KR20200062533A (en) * 2018-11-27 2020-06-04 신종걸 Apparatus for Checking Packaging Equipment Automation Machine

Also Published As

Publication number Publication date
KR20220167613A (en) 2022-12-21

Similar Documents

Publication Publication Date Title
KR100650285B1 (en) System for inspecting medicine packets
WO2011118860A1 (en) Automatic free-form tablet dispenser for medication packaging device and method for dispensing tablets thereby
WO2012121565A2 (en) Drug inspection apparatus and method for an automatic drug packing machine
KR100787806B1 (en) Division packing method and apparatus for medicine packing machine
AU2005306311B2 (en) Automated drug discrimination during dispensing
WO2022265320A1 (en) Drug packet inspection system
US8885914B2 (en) Apparatus and method for reinspecting prescription drugs
JPH09299448A (en) Medicine monitoring apparatus
CN103995949A (en) Medication dispensing apparatus for preventing medication dispensing error
KR20050096182A (en) Inspection device for loose objects, such as tablets
WO2016060499A1 (en) Hybrid inspection system and inspection method for drug
WO2022203151A1 (en) System for manufacturing customized health functional foods and tracking distribution history
WO2010002853A9 (en) Systems and methods for inspecting and grouping primary packages
KR101716620B1 (en) Apparatus of automatic packing and withdrawal for prescription drugs
BR112015032264B1 (en) METHOD FOR SUPPLYING AN OPEN TRANSPORTATION BOX AND OUTPUT / INPUT STATION FOR AN AUTOMATED STORAGE SYSTEM FOR MEDICINE PACKAGES
WO2021048835A2 (en) Watchdog system, watchdog method, and battery management system comprising watchdog system
JPH09253163A (en) Medicine monitoring support system
JPH05337168A (en) Automatic tablet packing machine
WO2017159891A1 (en) Drug rotating unit and drug dispensing apparatus having same
WO2015050312A1 (en) Apparatus for dispensing medicine and apparatus for packaging medicine comprising same
WO2023234566A1 (en) Drug packaging device and automated compounding facility including same
WO2018012835A1 (en) Drug pouch storage cabinet, and drug packaging apparatus comprising same
KR20160116856A (en) Apparatus for comparing drag and prescription
WO2020059976A1 (en) Shock-absorbing material supply apparatus used for article packaging device
WO2013015624A2 (en) Pill container allowing dosage confirmation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22825245

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22825245

Country of ref document: EP

Kind code of ref document: A1